MSc degree in ‘Development and Regulation of Medical Technologies’

​

Tel Aviv University offers a Master's degree in Development and Regulation of Medical Technologies at the Gray Faculty of Medical and Health Sciences. In collaboration with the Israeli Ministry of Health and 8400 Health Network, this pioneering program equips students with the essential knowledge required to navigate the complexities of therapeutic development and regulatory affairs.

​

Course Directors: Prof. Noam Shomron (Faculty of Medicine at Tel Aviv University) and Dr. Michal Roll (Pharma and Regulatory expert)

​

Overall Aims: The program is designed to bridge the gap between cutting-edge scientific innovations and the intricate regulatory landscape governing the development, approval, and post-marketing surveillance of medical products. Courses cover key topics such as drug development, medical device regulations & SaMD, AI in drug development, advanced therapies, clinical trials, and global regulatory systems.

​

Enrollment: Prospective students are evaluated based on academic performance, requiring a minimum Bachelor's degree GPA of 80, and a formal interview.

​

The Program:

This two-year program meets on Tuesdays (once weekly), including condensed summer sessions. Instruction: mostly Hebrew, with select courses in English. Students can choose between two tracks:

1. Internship Track: Undertaking immersive internships within the industry or governmental agencies during the second year, gaining hands-on experience in regulatory affairs. Students who already work in the industry or government can fit this degree with their daily jobs and do their internships there.

2. Research Track: Pursuing in-depth research projects culminating in an MSc thesis. Exceptional students may be eligible for scholarships.
    

Now accepting applications for our 5th cohort